Babić, M., Banović, M., Berečić, I., Banić, T., Babić Leko, M., Ulamec, M. ... Šimić, G. (2023). Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy. Journal of Clinical Medicine, 12. (15). doi: 10.3390/jcm12155060
Babić, Marija, et al. "Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy." Journal of Clinical Medicine, vol. 12, no. 15, 2023. https://doi.org/10.3390/jcm12155060
Babić, Marija, Maria Banović, Ivana Berečić, Tea Banić, Mirjana Babić Leko, Monika Ulamec, Alisa Junaković, et al. "Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy." Journal of Clinical Medicine 12, no. 15 (2023). https://doi.org/10.3390/jcm12155060
Babić, M., et al. (2023) 'Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy', Journal of Clinical Medicine, 12(15). doi: 10.3390/jcm12155060
Babić M, Banović M, Berečić I, Banić T, Babić Leko M, Ulamec M, and sur.. Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy. Journal of Clinical Medicine [Internet]. 2023 August 01 [cited 2024 October 05];12(15). doi: 10.3390/jcm12155060
M. Babić, et al., "Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy", Journal of Clinical Medicine, vol. 12, no. 15, August 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:001529. [Accessed: 05 October 2024]